ArticleJournal of the National Cancer Center2021

Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL).

Guangjian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.